Original Research
Published on 17 May 2024
PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes
in Cancer Immunity and Immunotherapy